Clinical Trial Update: Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients

View source ↗

Summary

This completed trial evaluated switching liver transplant recipients from sirolimus to everolimus as maintenance immunosuppression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Everolimus (everolimus)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Ege University | Conditions: Liver Transplant Recipients | Status: COMPLETED